Modified-release hydrocortisone to provide circadian cortisol profiles. - Wikidata - awgldk - TriplyDB

Modified-release hydrocortisone to provide circadian cortisol profiles.

Modified-release hydrocortisone to provide circadian cortisol profiles.

http://www.wikidata.org/entity/Q37198005

about

Brain-skin connection: stress, inflammation and skin aging Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline Is physiological glucocorticoid replacement important in children?Sex differences in the circadian profiles of melatonin and cortisol in plasma and urine matrices under constant routine conditions Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency Comorbid Latent Adrenal Insufficiency with Autoimmune Thyroid Disease Slow wave sleep and accelerated forgetting.Interactions of the human cardiopulmonary, hormonal and body fluid systems in parabolic flight.A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency Management of the adult with congenital adrenal hyperplasia.Circadian rhythms: from basic mechanisms to the intensive care unit.Influence of electric, magnetic, and electromagnetic fields on the circadian system: current stage of knowledge Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.A transgenic zebrafish model for monitoring glucocorticoid receptor activity Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey.Treatment and health outcomes in adults with congenital adrenal hyperplasia.Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.Absence of circadian rhythms of preterm premature rupture of membranes and preterm placental abruption.Impact of chronic hypercortisolemia on affective processing.Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genes Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy.Adult attachment style and cortisol responses in women in late pregnancy.Anti-Stress, Behavioural and Magnetoencephalography Effects of an L-Theanine-Based Nutrient Drink: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial Inhibition of MDMA-induced increase in cortisol does not prevent acute impairment of verbal memory Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Novel treatment strategies in congenital adrenal hyperplasia.Subjective aggression during alcohol and cannabis intoxication before and after aggression exposure.Reduction of Cortisol Levels and Participants' Responses Following Art Making.Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study Acute Effects of 24-h Sleep Deprivation on Salivary Cortisol and Testosterone Concentrations and Testosterone to Cortisol Ratio Following Supplementation with Caffeine or Placebo.Adrenal cortical insufficiency--a life threatening illness with multiple etiologies.An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure.Therapy of adrenal insufficiency: an update.Cardio-metabolic consequences of glucocorticoid replacement: relevance of ultradian signalling.

P2860

Q24563348-BF71C5A8-00B5-4CB4-A501-EE22FAD43474 Q24614223-7C7D70B2-B4C3-410F-8042-F11CDD461D43 Q28079724-087AD962-4884-44E1-8E5B-A6AA64D17EA4 Q28391241-C9D2DE4B-498C-4D8B-B6C5-0DFCD419CE17 Q28547592-78CCDB80-68F7-4E92-BAF4-ED37CAA49B14 Q28607675-9D122C74-6D2F-41AC-9FCE-FB1A458BDDBF Q30370893-32B67189-3358-481C-892E-4286FAE73BC1 Q30577964-601CE29F-8CAC-4CCA-87E2-C225CCBD1B18 Q33570221-CB94EC8C-4713-46F1-BF26-AB31F3E42592 Q33659999-CF332D6D-20B1-43BD-960C-E24BE349C058 Q33835797-A354E80C-B16D-4B86-ADD7-6657C716F153 Q33931519-475DCD97-9478-4822-8426-271E1A6D0B1D Q33960872-3689DFEF-A07F-4DE1-8747-CEE223221D57 Q34021701-4251B566-86A3-4BCE-9D4E-43FD534337A9 Q34033539-C572DE1B-7C99-424B-9778-71A311DB50FF Q34180545-480413A3-304D-43C0-8A6C-6A07892D1407 Q34257797-7D430645-CCDD-424F-A850-F65D1221EEBB Q34303186-DC052C6A-702B-4BCA-9451-6316A76AA4D2 Q34392232-EF18F5D2-2B76-49F4-AF96-FA080FEA661D Q34734248-E1264CB2-AC82-4424-AE0E-3BCF96E481B3 Q34794021-79899898-72D6-4099-9FC8-F81187959345 Q35163932-52089E2A-3EBF-4A67-9176-59E63024A783 Q35380838-6AFFD523-41E7-40BB-9DE5-6E67D539FC63 Q35820948-DC1B5554-DEA3-4BE2-8558-C677FBADDC2C Q36197083-E3C826C2-FCFD-44C2-A4AB-AEA4120F3681 Q36329903-CB138E78-B990-4D62-865F-DB7F0F0631FB Q36454515-1E3754FC-6AED-4EAA-9151-F9DE824E265B Q36507543-E09B47B4-5563-4A7F-B464-7D07FD87AA46 Q36629185-1A56DD58-4728-40BF-975A-09578A5CD4C7 Q36795530-0EA07F4A-C7FF-4ABD-981A-D8FD0602ADC7 Q36981641-67CB6FAE-6FFD-4A52-8B23-9C1ABECB352D Q37184415-BB421637-166A-4038-B0F2-E3B991CE8DCF Q37217091-FE86FD65-781A-4E50-8A43-A995B65E0904 Q37246781-A4A1CA65-05C9-4865-9735-3C79D6170263 Q37341137-F21F6313-BF4B-4903-A233-5F0452EA1FB9 Q37558923-192F6A5B-53E9-43FF-851F-C3C7F52EFE04 Q37592058-311990D3-ADF5-4098-978A-E1153B9DE7E0 Q37607948-C89C91AC-BDDC-4A54-B84F-BFB087FE267D Q38062413-C5FA658B-E108-44EA-B65C-D78036822E8C Q38194625-AD482397-398C-4757-A2B8-28E0FC84E6C1

P2860

Modified-release hydrocortisone to provide circadian cortisol profiles.

http://www.wikidata.org/entity/Q37198005

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modified-release hydrocortisone to provide circadian cortisol profiles.

@en

Modified-release hydrocortisone to provide circadian cortisol profiles.

@nl

type

label

Modified-release hydrocortisone to provide circadian cortisol profiles.

@en

Modified-release hydrocortisone to provide circadian cortisol profiles.

@nl

prefLabel

Modified-release hydrocortisone to provide circadian cortisol profiles.

@en

Modified-release hydrocortisone to provide circadian cortisol profiles.

@nl

P1433

Q37198005-1A3E3030-68F6-4E44-8DDB-4A860E6835AD

P1476

Q37198005-E870112A-3FED-4E71-9F65-183306D3D779

P2093

Q37198005-0C011900-914F-4A6F-A5C0-FABADC6314B0

Q37198005-1C5BA917-928A-40F5-96DE-68838BD10F9C

Q37198005-766FFD1A-1C73-4543-9B98-B5119DE1391E

Q37198005-7EA769C4-5F1E-4249-8C56-9B2E06D9289B

Q37198005-91DE419C-7591-4C89-BCE1-9B5C35C8B341

Q37198005-AF6CA2CD-8720-4CD9-ADB5-F15DE1110021

Q37198005-B84ED9E0-24C4-4B01-AB53-80580EEB13FD

Q37198005-E0037FDE-FF21-4BD8-9D78-7DFD16826FFD

P2860

Q37198005-02050830-122B-48D1-B2B8-E632BA1520B1

Q37198005-0AA1BEE0-C605-4E86-9617-E5D23043E598

Q37198005-0CDE2853-D524-42AC-8269-5B9DA52A1F94

Q37198005-1972C505-AF4F-422F-885D-84B341E2F3E3

Q37198005-19789973-C6F0-42C3-B898-AB96E2734EBB

Q37198005-1E56034E-F8A0-4DF5-858C-E0CA6355E830

Q37198005-208C14F7-CFBC-4728-9F12-4CC7DC57CD26

Q37198005-2C2535F2-BF81-4130-BF35-8834CC82AD58

Q37198005-4C783358-B240-4701-86D8-004549702EC3

Q37198005-4E4DC6E1-1378-4592-B7C6-984576780F2E

P304

Q37198005-C9BA2310-6BE4-47A7-A174-8DCDC4CB9FE0

P31

Q37198005-0551DC5E-AECA-4E26-9D85-CD8DB49C9858

P356

Q37198005-8D187E43-B3D1-4DE9-AEAB-F1B8C93AFE69

P407

Q37198005-70D9A1DE-E599-4684-BD58-DE781D50D4C8

P433

Q37198005-5C9AA066-1E94-47DE-810F-D5DC912D64B0

P478

Q37198005-A347ADD3-B7EF-4FC3-9BA1-147B8C97E1AC

P50

Q37198005-E1C6C7D7-FF5D-4105-A19B-45ED15D10338

Q37198005-E66F98EC-C3B4-4A83-855D-0B5A32118C47

P577

Q37198005-2ACD902D-B48E-4772-B482-5CD02B23270C

P5875

Q37198005-0433618D-DF8C-4207-A411-099A31DC6FD9

P698

Q37198005-51B0F33B-2BEC-4412-BDD2-91C0BB787BE8

P921

Q37198005-3b95e16e-f4b9-4152-a036-174ea43e8452

Q37198005-73994E8C-B957-4619-A449-9D22444114BA

P932

Q37198005-E291220E-59B7-4E1E-9E35-E945F62D4DC2

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Modified-release hydrocortisone to provide circadian cortisol profiles.

@en

P2093

Amin Rostami-Hodjegan

http://www.w3.org/2001/XMLSchema#string

Cyrus Ghobadi

http://www.w3.org/2001/XMLSchema#string

Deborah P Merke

http://www.w3.org/2001/XMLSchema#string

Hiep Huatan

http://www.w3.org/2001/XMLSchema#string

John Newell-Price

http://www.w3.org/2001/XMLSchema#string

Ken Darzy

http://www.w3.org/2001/XMLSchema#string

Miguel Debono

http://www.w3.org/2001/XMLSchema#string

Richard J Ross

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of sleep debt on metabolic and endocrine function

Molecular bases for circadian clocks

A serum shock induces circadian gene expression in mammalian tissue culture cells

Resetting of circadian time in peripheral tissues by glucocorticoid signaling

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.

Adrenal insufficiency.

Diurnal variation of aldosterone and plasma renin activity: timing relation to melatonin and cortisol and consistency after prolonged bed rest.

On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders.

Why is the management of glucocorticoid deficiency still controversial: a review of the literature.

Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis.

P304

1548-1554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2008-2380

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Campbell

P577

2009-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24021501

http://www.w3.org/2001/XMLSchema#string

P698

19223520

http://www.w3.org/2001/XMLSchema#string

P921

circadian rhythm

P932

2684472

http://www.w3.org/2001/XMLSchema#string